echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > MMWR: Clinical features and outcomes of laboratory-confirmed SARS-CoV-2-infected adults hospitalized during periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant predominance

    MMWR: Clinical features and outcomes of laboratory-confirmed SARS-CoV-2-infected adults hospitalized during periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant predominance

    • Last Update: 2022-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: In mid-December 2021, the B.
    1.
    1.
    529 (Omicron) variant of SARS-CoV-2 that causes COVID-19 surpassed the B.
    1.
    617.
    2 (Delta) variant to become the dominant strain in California
    .


    Preliminary reports suggest that the omicron variant is more transmissible and resistant to vaccine neutralization, but causes less severe disease than previous variants


    In mid-December 2021, the B.


    RESULTS: Adults admitted during Ogilvy's dominance period received the last (full) dose of the COVID-19 primary vaccine series at a higher rate (39.
    6% vs.
    There are fewer guidelines for treatment of new coronary pneumonia
    .


    Although fewer intensive care unit (ICU) admissions and invasive mechanical ventilation (IMV) were required during Omicron's predominance, as well as fewer deaths during hospitalization, after stratification by vaccination status , there were no significant differences in ICU admission or invasive mechanical ventilation (IMV)


    Figure 737 adults with sars-cov-2 infection died during intensive care unit admission, use of invasive mechanical ventilation, and hospitalization during the omicron variant epidemic, by age group and vaccination status*

    Table 2.
    Demographics, clinical characteristics, and clinical outcomes of 131 adults infected with SARS-CoV-2 early in the Omicron variant

    Conclusions: Vaccination, including escalating doses for those who are fully vaccinated, remains critical to minimizing the risk of serious health consequences in adults infected with SARS-CoV-2
    .

    Vaccination, including escalating doses for those who are fully vaccinated, remains critical to minimizing the risk of serious health consequences in adults infected with SARS-CoV-2
    .


    Original source: Modes ME, Directo MP, Melgar M, et al.


    Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.
    1.
    617.
    2 (Delta) and B.
    1.
    1.
    529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23 , 2021, and December 21, 2021-January 27, 2022Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.